{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,5]],"date-time":"2026-09-05T01:23:50Z","timestamp":1788571430447,"version":"build-2803163510"},"reference-count":61,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,3,25]],"date-time":"2024-03-25T00:00:00Z","timestamp":1711324800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2024,3,25]],"date-time":"2024-03-25T00:00:00Z","timestamp":1711324800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100004325","name":"AstraZeneca","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004325","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Ital J Pediatr"],"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>Respiratory Syncytial Virus (RSV) infections may lead to severe consequences in infants born preterm with breathing problems (such as bronchopulmonary dysplasia (BPD) and respiratory distress syndrome (RDS)) or congenital heart diseases (CHD). Since studies investigating the influence of different gestational age (WGA) and concomitant specific comorbidities on the burden of RSV infections are scarce, the present study aimed to better characterize these high-risk populations in the Italian context.\n<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>This retrospective, longitudinal and record-linkage cohort study involved infants born between 2017 and 2019 in Lazio Region (Italy) and is based on data extracted from administrative databases. Each infant was exclusively included in one of the following cohorts: (1) BPD-RDS (WGA \u226435 with or without CHD) or (2) CHD (without BPD and\/or RDS) or (3) Preterm (WGA \u226435 without BPD (and\/or RDS) or CHD). Each cohort was followed for 12 months from birth. Information related to sociodemographic at birth, and RSV and Undetermined Respiratory Agents (URA) hospitalizations and drug consumption at follow-up were retrieved and described.\n<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>A total of 8,196 infants were selected and classified as 1,084 BPD-RDS, 3,286 CHD and 3,826 Preterm. More than 30% of the BPD-RDS cohort was composed by early preterm infants (WGA \u2264 29) in contrast to the Preterm cohort predominantly constitute by moderate preterm infants (98.2%), while CHD infants were primarily born at term (83.9%). At follow-up, despite the cohorts showed similar proportions of RSV hospitalizations, in BPD-RDS cohort hospitalizations were more frequently severe compared to those occurred in the Preterm cohort (<jats:italic>p<\/jats:italic>&lt;0.01), in the BPD-RDS cohort was also found the highest proportion of URA hospitalizations (<jats:italic>p<\/jats:italic>&lt;0.0001). In addition, BPD-RDS infants, compared to those of the remaining cohorts, received more frequently prophylaxis with palivizumab (<jats:italic>p<\/jats:italic>&lt;0.0001) and were more frequently treated with adrenergics inhalants, and glucocorticoids for systemic use.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusions<\/jats:title>\n                <jats:p>The assessment of the study clinical outcomes highlighted that, the demographic and clinical characteristics at birth of the study cohorts influence their level of vulnerability to RSV and URA infections. As such, continuous monitoring of these populations is necessary in order to ensure a timely organization of health care system able to respond to their needs in the future.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s13052-024-01627-8","type":"journal-article","created":{"date-parts":[[2024,3,25]],"date-time":"2024-03-25T10:01:45Z","timestamp":1711360905000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["An epidemiological investigation of high-risk infants for Respiratory Syncytial Virus infections: a retrospective cohort study"],"prefix":"10.1186","volume":"50","author":[{"given":"Michela","family":"Servadio","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marco","family":"Finocchietti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chiara","family":"Vassallo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Riccardo","family":"Cipelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Franca","family":"Heiman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giulia","family":"Di Lucchio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bianca","family":"Oresta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0962-9959","authenticated-orcid":false,"given":"Antonio","family":"Addis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Valeria","family":"Belleudi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,3,25]]},"reference":[{"issue":"8","key":"1627_CR1","doi-asserted-by":"publisher","first-page":"2351","DOI":"10.1007\/s00705-016-2880-1","volume":"161","author":"CL Afonso","year":"2016","unstructured":"Afonso CL, Amarasinghe GK, B\u00e1nyai K, B\u00e0o Y, Basler CF, Bavari S, et al. Taxonomy of the order Mononegavirales: update 2016. Arch Virol. 2016;161(8):2351\u201360.","journal-title":"Arch Virol"},{"issue":"12","key":"1627_CR2","doi-asserted-by":"publisher","first-page":"2912","DOI":"10.1099\/jgv.0.000959","volume":"98","author":"B Rima","year":"2017","unstructured":"Rima B, Collins P, Easton A, Fouchier R, Kurath G, Lamb RA, et al. ICTV Virus Taxonomy Profile: Pneumoviridae. J Gen Virol. 2017;98(12):2912\u20133.","journal-title":"J Gen Virol"},{"issue":"10098","key":"1627_CR3","doi-asserted-by":"publisher","first-page":"946","DOI":"10.1016\/S0140-6736(17)30938-8","volume":"390","author":"T Shi","year":"2017","unstructured":"Shi T, McAllister DA, O'Brien KL, Simoes EAF, Madhi SA, Gessner BD, et al. Global, regional, and national disease burden estimates of acute lower respiratory infections due to respiratory syncytial virus in young children in 2015: a systematic review and modelling study. Lancet. 2017;390(10098):946\u201358.","journal-title":"Lancet."},{"issue":"12","key":"1627_CR4","doi-asserted-by":"publisher","first-page":"519","DOI":"10.1542\/pir.35.12.519","volume":"35","author":"G Piedimonte","year":"2014","unstructured":"Piedimonte G, Perez MK. Respiratory syncytial virus infection and bronchiolitis. Pediatr Rev. 2014;35(12):519\u201330.","journal-title":"Pediatr Rev"},{"issue":"9","key":"1627_CR5","doi-asserted-by":"publisher","first-page":"1356","DOI":"10.1093\/infdis\/jiy056","volume":"217","author":"P Obando-Pacheco","year":"2018","unstructured":"Obando-Pacheco P, Justicia-Grande AJ, Rivero-Calle I, Rodr\u00edguez-Tenreiro C, Sly P, Ramilo O, et al. Respiratory Syncytial Virus Seasonality: A Global Overview. J Infect Dis. 2018;217(9):1356\u201364.","journal-title":"J Infect Dis"},{"issue":"8","key":"1627_CR6","doi-asserted-by":"publisher","first-page":"e1031","DOI":"10.1016\/S2214-109X(19)30264-5","volume":"7","author":"Y Li","year":"2019","unstructured":"Li Y, Reeves RM, Wang X, Bassat Q, Brooks WA, Cohen C, et al. Global patterns in monthly activity of influenza virus, respiratory syncytial virus, parainfluenza virus, and metapneumovirus: a systematic analysis. Lancet Glob Health. 2019;7(8):e1031\u2013e45.","journal-title":"Lancet Glob Health"},{"issue":"10340","key":"1627_CR7","doi-asserted-by":"publisher","first-page":"2047","DOI":"10.1016\/S0140-6736(22)00478-0","volume":"399","author":"Y Li","year":"2022","unstructured":"Li Y, Wang X, Blau DM, Caballero MT, Feikin DR, Gill CJ, et al. Global, regional, and national disease burden estimates of acute lower respiratory infections due to respiratory syncytial virus in children younger than 5 years in 2019: a systematic analysis. Lancet. 2022;399(10340):2047\u201364.","journal-title":"Lancet."},{"key":"1627_CR8","doi-asserted-by":"crossref","unstructured":"Barbati F, Moriondo M, Pisano L, Calistri E, Lodi L, Ricci S, et al. Epidemiology of Respiratory Syncytial Virus-Related Hospitalization Over a 5-Year Period in Italy: Evaluation of Seasonality and Age Distribution Before Vaccine Introduction. Vaccines (Basel). 2020;8(1)","DOI":"10.3390\/vaccines8010015"},{"issue":"17","key":"1627_CR9","doi-asserted-by":"publisher","first-page":"1749","DOI":"10.1056\/NEJMoa043951","volume":"352","author":"AR Falsey","year":"2005","unstructured":"Falsey AR, Hennessey PA, Formica MA, Cox C, Walsh EE. Respiratory syncytial virus infection in elderly and high-risk adults. N Engl J Med. 2005;352(17):1749\u201359.","journal-title":"N Engl J Med"},{"issue":"Suppl 7","key":"1627_CR10","doi-asserted-by":"publisher","first-page":"S577","DOI":"10.1093\/infdis\/jiz059","volume":"222","author":"T Shi","year":"2020","unstructured":"Shi T, Denouel A, Tietjen AK, Campbell I, Moran E, Li X, et al. Global Disease Burden Estimates of Respiratory Syncytial Virus-Associated Acute Respiratory Infection in Older Adults in 2015: A Systematic Review and Meta-Analysis. J Infect Dis. 2020;222(Suppl 7):S577\u201383.","journal-title":"J Infect Dis"},{"issue":"9725","key":"1627_CR11","doi-asserted-by":"publisher","first-page":"1545","DOI":"10.1016\/S0140-6736(10)60206-1","volume":"375","author":"H Nair","year":"2010","unstructured":"Nair H, Nokes DJ, Gessner BD, Dherani M, Madhi SA, Singleton RJ, et al. Global burden of acute lower respiratory infections due to respiratory syncytial virus in young children: a systematic review and meta-analysis. Lancet. 2010;375(9725):1545\u201355.","journal-title":"Lancet."},{"issue":"2","key":"1627_CR12","doi-asserted-by":"publisher","first-page":"e341","DOI":"10.1542\/peds.2013-0303","volume":"132","author":"CB Hall","year":"2013","unstructured":"Hall CB, Weinberg GA, Blumkin AK, Edwards KM, Staat MA, Schultz AF, et al. Respiratory syncytial virus-associated hospitalizations among children less than 24 months of age. Pediatrics. 2013;132(2):e341\u20138.","journal-title":"Pediatrics."},{"issue":"3","key":"1627_CR13","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1007\/s40121-016-0123-0","volume":"5","author":"L Bont","year":"2016","unstructured":"Bont L, Checchia PA, Fauroux B, Figueras-Aloy J, Manzoni P, Paes B, et al. Defining the Epidemiology and Burden of Severe Respiratory Syncytial Virus Infection Among Infants and Children in Western Countries. Infect Dis Ther. 2016;5(3):271\u201398.","journal-title":"Infect Dis Ther"},{"key":"1627_CR14","doi-asserted-by":"publisher","first-page":"144","DOI":"10.2174\/1874285801105010144","volume":"5","author":"C Sommer","year":"2011","unstructured":"Sommer C, Resch B, Sim\u00f5es EA. Risk factors for severe respiratory syncytial virus lower respiratory tract infection. Open Microbiol J. 2011;5:144\u201354.","journal-title":"Open Microbiol J"},{"issue":"6","key":"1627_CR15","doi-asserted-by":"publisher","first-page":"865","DOI":"10.1067\/mpd.2000.110531","volume":"137","author":"TG Boyce","year":"2000","unstructured":"Boyce TG, Mellen BG, Mitchel EF, Wright PF, Griffin MR. Rates of hospitalization for respiratory syncytial virus infection among children in medicaid. J Pediatr. 2000;137(6):865\u201370.","journal-title":"J Pediatr"},{"issue":"3","key":"1627_CR16","doi-asserted-by":"publisher","first-page":"e0172512","DOI":"10.1371\/journal.pone.0172512","volume":"12","author":"D Friedman","year":"2017","unstructured":"Friedman D, Fryzek J, Jiang X, Bloomfield A, Ambrose CS, Wong PC. Respiratory syncytial virus hospitalization risk in the second year of life by specific congenital heart disease diagnoses. PLoS One. 2017;12(3):e0172512.","journal-title":"PLoS One"},{"issue":"5","key":"1627_CR17","doi-asserted-by":"publisher","first-page":"e0197410","DOI":"10.1371\/journal.pone.0197410","volume":"13","author":"H Chi","year":"2018","unstructured":"Chi H, Chung CH, Lin YJ, Lin CH. Seasonal peaks and risk factors of respiratory syncytial virus infections related hospitalization of preterm infants in Taiwan. PLoS One. 2018;13(5):e0197410.","journal-title":"PLoS One"},{"key":"1627_CR18","unstructured":"European Medicines Agency. European public assessment report (EPAR) for Synagis. 13 August 1999. (Accessed 05 05 2023)."},{"key":"1627_CR19","unstructured":"European Medicines Agency. 15 November 2022. (accessed 05 Aprile 2023)."},{"issue":"11","key":"1627_CR20","first-page":"994","volume":"92","author":"CL Hermansen","year":"2015","unstructured":"Hermansen CL, Mahajan A. Newborn Respiratory Distress. Am Fam Physician. 2015;92(11):994\u20131002.","journal-title":"Am Fam Physician"},{"issue":"12","key":"1627_CR21","doi-asserted-by":"publisher","first-page":"1245","DOI":"10.1097\/INF.0b013e3182737349","volume":"31","author":"SM Szabo","year":"2012","unstructured":"Szabo SM, Gooch KL, Korol EE, Bradt P, Vo P, Levy AR. Respiratory distress syndrome at birth is a risk factor for hospitalization for lower respiratory tract infections in infancy. Pediatr Infect Dis J. 2012;31(12):1245\u201351.","journal-title":"Pediatr Infect Dis J"},{"issue":"5","key":"1627_CR22","doi-asserted-by":"publisher","first-page":"469","DOI":"10.1016\/j.aller.2014.06.006","volume":"43","author":"I Olabarrieta","year":"2015","unstructured":"Olabarrieta I, Gonzalez-Carrasco E, Calvo C, Pozo F, Casas I, Garc\u00eda-Garc\u00eda ML. Hospital admission due to respiratory viral infections in moderate preterm, late preterm and term infants during their first year of life. Allergol Immunopathol (Madr). 2015;43(5):469\u201373.","journal-title":"Allergol Immunopathol (Madr)"},{"issue":"11","key":"1627_CR23","doi-asserted-by":"publisher","first-page":"1721","DOI":"10.1080\/14767058.2019.1646240","volume":"34","author":"C Siffel","year":"2021","unstructured":"Siffel C, Kistler KD, Lewis JFM, Sarda SP. Global incidence of bronchopulmonary dysplasia among extremely preterm infants: a systematic literature review. J Matern Fetal Neonatal Med. 2021;34(11):1721\u201331.","journal-title":"J Matern Fetal Neonatal Med"},{"key":"1627_CR24","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1016\/j.jpeds.2018.07.024","volume":"202","author":"KR Kumar","year":"2018","unstructured":"Kumar KR, Clark DA, Kim EM, Perry JD, Wright K, Thomas SA, et al. Association of Atrial Septal Defects and Bronchopulmonary Dysplasia in Premature Infants. J Pediatr. 2018;202:56\u201362.e2.","journal-title":"J Pediatr"},{"issue":"1","key":"1627_CR25","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1111\/chd.12691","volume":"14","author":"KA Willis","year":"2019","unstructured":"Willis KA, Weems MF. Hemodynamically significant patent ductus arteriosus and the development of bronchopulmonary dysplasia. Congenit Heart Dis. 2019;14(1):27\u201332.","journal-title":"Congenit Heart Dis"},{"issue":"4","key":"1627_CR26","doi-asserted-by":"publisher","first-page":"417","DOI":"10.1007\/s40121-016-0130-1","volume":"5","author":"J Figueras-Aloy","year":"2016","unstructured":"Figueras-Aloy J, Manzoni P, Paes B, Sim\u00f5es EA, Bont L, Checchia PA, et al. Defining the Risk and Associated Morbidity and Mortality of Severe Respiratory Syncytial Virus Infection Among Preterm Infants Without Chronic Lung Disease or Congenital Heart Disease. Infect Dis Ther. 2016;5(4):417\u201352.","journal-title":"Infect Dis Ther"},{"issue":"4","key":"1627_CR27","doi-asserted-by":"publisher","first-page":"453","DOI":"10.1007\/s40121-016-0137-7","volume":"5","author":"B Paes","year":"2016","unstructured":"Paes B, Fauroux B, Figueras-Aloy J, Bont L, Checchia PA, Sim\u00f5es EA, et al. Defining the Risk and Associated Morbidity and Mortality of Severe Respiratory Syncytial Virus Infection Among Infants with Chronic Lung Disease. Infect Dis Ther. 2016;5(4):453\u201371.","journal-title":"Infect Dis Ther"},{"issue":"1","key":"1627_CR28","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1007\/s40121-016-0142-x","volume":"6","author":"PA Checchia","year":"2017","unstructured":"Checchia PA, Paes B, Bont L, Manzoni P, Sim\u00f5es EA, Fauroux B, et al. Defining the Risk and Associated Morbidity and Mortality of Severe Respiratory Syncytial Virus Infection Among Infants with Congenital Heart Disease. Infect Dis Ther. 2017;6(1):37\u201356.","journal-title":"Infect Dis Ther"},{"issue":"9","key":"1627_CR29","doi-asserted-by":"publisher","first-page":"381","DOI":"10.14745\/ccdr.v47i09a05","volume":"47","author":"A Wingert","year":"2021","unstructured":"Wingert A, Pillay J, Moore DL, Guitard S, Vandermeer B, Dyson MP, et al. Burden of illness in infants and young children hospitalized for respiratory syncytial virus: A rapid review. Can Commun Dis Rep. 2021;47(9):381\u201396.","journal-title":"Can Commun Dis Rep"},{"issue":"1","key":"1627_CR30","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1016\/S1084-2756(02)00192-6","volume":"8","author":"E Bancalari","year":"2003","unstructured":"Bancalari E, Claure N, Sosenko IR. Bronchopulmonary dysplasia: changes in pathogenesis, epidemiology and definition. Semin Neonatol. 2003;8(1):63\u201371.","journal-title":"Semin Neonatol"},{"issue":"1","key":"1627_CR31","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1159\/000528914","volume":"120","author":"DG Sweet","year":"2023","unstructured":"Sweet DG, Carnielli VP, Greisen G, Hallman M, Klebermass-Schrehof K, Ozek E, et al. European Consensus Guidelines on the Management of Respiratory Distress Syndrome: 2022 Update. Neonatology. 2023;120(1):3\u201323.","journal-title":"Neonatology."},{"issue":"3","key":"1627_CR32","doi-asserted-by":"publisher","first-page":"443","DOI":"10.1542\/peds.2009-2959","volume":"126","author":"BJ Stoll","year":"2010","unstructured":"Stoll BJ, Hansen NI, Bell EF, Shankaran S, Laptook AR, Walsh MC, et al. Neonatal outcomes of extremely preterm infants from the NICHD Neonatal Research Network. Pediatrics. 2010;126(3):443\u201356.","journal-title":"Pediatrics."},{"issue":"11","key":"1627_CR33","doi-asserted-by":"publisher","first-page":"e012872","DOI":"10.1136\/bmjopen-2016-012872","volume":"6","author":"S Klevebro","year":"2016","unstructured":"Klevebro S, Lundgren P, Hammar U, Smith LE, Bottai M, Domell\u00f6f M, et al. Cohort study of growth patterns by gestational age in preterm infants developing morbidity. BMJ Open. 2016;6(11):e012872.","journal-title":"BMJ Open"},{"issue":"3","key":"1627_CR34","doi-asserted-by":"publisher","first-page":"248","DOI":"10.1001\/jama.2021.23580","volume":"327","author":"EF Bell","year":"2022","unstructured":"Bell EF, Hintz SR, Hansen NI, Bann CM, Wyckoff MH, DeMauro SB, et al. Mortality, In-Hospital Morbidity, Care Practices, and 2-Year Outcomes for Extremely Preterm Infants in the US, 2013-2018. JAMA. 2022;327(3):248\u201363.","journal-title":"JAMA."},{"issue":"2","key":"1627_CR35","doi-asserted-by":"publisher","first-page":"147","DOI":"10.36469\/jheor.2022.38847","volume":"9","author":"ME Mowitz","year":"2022","unstructured":"Mowitz ME, Gao W, Sipsma H, Zuckerman P, Wong H, Ayyagari R, et al. Burden of Comorbidities and Healthcare Resource Utilization Among Medicaid-Enrolled Extremely Premature Infants. J Health Econ Outcomes Res. 2022;9(2):147\u201355.","journal-title":"J Health Econ Outcomes Res"},{"issue":"5","key":"1627_CR36","doi-asserted-by":"publisher","first-page":"503","DOI":"10.1016\/j.pedneo.2022.05.007","volume":"63","author":"ME Mowitz","year":"2022","unstructured":"Mowitz ME, Gao W, Sipsma H, Zuckerman P, Wong H, Ayyagari R, et al. Long-term burden of respiratory complications associated with extreme prematurity: An analysis of US Medicaid claims. Pediatr Neonatol. 2022;63(5):503\u201311.","journal-title":"Pediatr Neonatol"},{"issue":"6","key":"1627_CR37","doi-asserted-by":"publisher","first-page":"1104","DOI":"10.1007\/s00134-013-2887-y","volume":"39","author":"A Polito","year":"2013","unstructured":"Polito A, Piga S, Cogo PE, Corchia C, Carnielli V, Da Fr\u00e8 M, et al. Increased morbidity and mortality in very preterm\/VLBW infants with congenital heart disease. Intensive Care Med. 2013;39(6):1104\u201312.","journal-title":"Intensive Care Med"},{"issue":"12","key":"1627_CR38","doi-asserted-by":"publisher","first-page":"1113","DOI":"10.4070\/kcj.2020.0135","volume":"50","author":"WS Song","year":"2020","unstructured":"Song WS, Kim CY, Lee BS, Kim EAR, Kim KS, Jung E. Morbidity and Mortality of Very Low Birth Weight Infants with Congenital Heart Disease. Korean Circ J. 2020;50(12):1113\u201323.","journal-title":"Korean Circ J"},{"issue":"2","key":"1627_CR39","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1053\/j.semperi.2013.01.006","volume":"37","author":"RI Clyman","year":"2013","unstructured":"Clyman RI. The role of patent ductus arteriosus and its treatments in the development of bronchopulmonary dysplasia. Semin Perinatol. 2013;37(2):102\u20137.","journal-title":"Semin Perinatol"},{"issue":"6","key":"1627_CR40","doi-asserted-by":"publisher","first-page":"786","DOI":"10.1016\/j.jpeds.2005.06.039","volume":"147","author":"W Oh","year":"2005","unstructured":"Oh W, Poindexter BB, Perritt R, Lemons JA, Bauer CR, Ehrenkranz RA, et al. Association between fluid intake and weight loss during the first ten days of life and risk of bronchopulmonary dysplasia in extremely low birth weight infants. J Pediatr. 2005;147(6):786\u201390.","journal-title":"J Pediatr"},{"issue":"1","key":"1627_CR41","doi-asserted-by":"publisher","first-page":"130","DOI":"10.1038\/s41372-019-0548-x","volume":"40","author":"W Lapcharoensap","year":"2020","unstructured":"Lapcharoensap W, Bennett MV, Xu X, Lee HC, Dukhovny D. Hospitalization costs associated with bronchopulmonary dysplasia in the first year of life. J Perinatol. 2020;40(1):130\u20137.","journal-title":"J Perinatol"},{"key":"1627_CR42","doi-asserted-by":"publisher","first-page":"510","DOI":"10.3389\/fped.2019.00510","volume":"7","author":"ME Mowitz","year":"2019","unstructured":"Mowitz ME, Ayyagari R, Gao W, Zhao J, Mangili A, Sarda SP. Health Care Burden of Bronchopulmonary Dysplasia Among Extremely Preterm Infants. Front Pediatr. 2019;7:510.","journal-title":"Front Pediatr"},{"key":"1627_CR43","doi-asserted-by":"crossref","unstructured":"Hardelid P, Verfuerden M, McMenamin J, Smyth RL, Gilbert R. The contribution of child, family and health service factors to respiratory syncytial virus (RSV) hospital admissions in the first 3 years of life: birth cohort study in Scotland, 2009 to 2015. Euro Surveill. 2019;24(1)","DOI":"10.2807\/1560-7917.ES.2019.24.1.1800046"},{"issue":"1","key":"1627_CR44","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1186\/s13052-018-0492-y","volume":"44","author":"P Kuhdari","year":"2018","unstructured":"Kuhdari P, Brosio F, Malaventura C, Stefanati A, Orsi A, Icardi G, et al. Human respiratory syncytial virus and hospitalization in young children in Italy. Ital J Pediatr. 2018;44(1):50.","journal-title":"Ital J Pediatr"},{"issue":"1","key":"1627_CR45","doi-asserted-by":"publisher","first-page":"e13066","DOI":"10.1111\/irv.13066","volume":"17","author":"T Bandeira","year":"2023","unstructured":"Bandeira T, Carmo M, Lopes H, Gomes C, Martins M, Guzman C, et al. Burden and severity of children's hospitalizations by respiratory syncytial virus in Portugal, 2015-2018. Influenza Other Respir Viruses. 2023;17(1):e13066.","journal-title":"Influenza Other Respir Viruses"},{"issue":"1","key":"1627_CR46","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1097\/INF.0b013e31822e68e6","volume":"31","author":"LJ Stockman","year":"2012","unstructured":"Stockman LJ, Curns AT, Anderson LJ, Fischer-Langley G. Respiratory syncytial virus-associated hospitalizations among infants and young children in the United States, 1997-2006. Pediatr Infect Dis J. 2012;31(1):5\u20139.","journal-title":"Pediatr Infect Dis J"},{"issue":"12","key":"1627_CR47","doi-asserted-by":"publisher","first-page":"1077","DOI":"10.1097\/INF.0b013e3181efdac5","volume":"29","author":"C Medrano L\u00f3pez","year":"2010","unstructured":"Medrano L\u00f3pez C, Garc\u00eda-Guereta L, Group CS. Community-acquired respiratory infections in young children with congenital heart diseases in the palivizumab era: the Spanish 4-season civic epidemiologic study. Pediatr Infect Dis J. 2010;29(12):1077\u201382.","journal-title":"Pediatr Infect Dis J"},{"issue":"5","key":"1627_CR48","doi-asserted-by":"publisher","first-page":"395","DOI":"10.1111\/j.1440-1754.2011.02219.x","volume":"48","author":"PM Alexander","year":"2012","unstructured":"Alexander PM, Eastaugh L, Royle J, Daley A, Shekerdemian LS, Penny DJ. Respiratory syncytial virus immunoprophylaxis in high-risk infants with heart disease. J Paediatr Child Health. 2012;48(5):395\u2013401.","journal-title":"J Paediatr Child Health"},{"issue":"1","key":"1627_CR49","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1186\/s13052-022-01399-z","volume":"49","author":"C Ratti","year":"2023","unstructured":"Ratti C, Greca AD, Bertoncelli D, Rubini M, Tchana B. Prophylaxis protects infants with congenital heart disease from severe forms of RSV infection: an Italian observational retrospective study : Palivizumab prophylaxis in children with congenital heart disease. Ital J Pediatr. 2023;49(1):4.","journal-title":"Ital J Pediatr"},{"issue":"3","key":"1627_CR50","doi-asserted-by":"publisher","first-page":"1246","DOI":"10.1111\/bcp.15069","volume":"88","author":"A Zylbersztejn","year":"2022","unstructured":"Zylbersztejn A, Almossawi O, Gudka N, Tompsett D, De Stavola B, Standing JF, et al. Access to palivizumab among children at high risk of respiratory syncytial virus complications in English hospitals. Br J Clin Pharmacol. 2022;88(3):1246\u201357.","journal-title":"Br J Clin Pharmacol"},{"issue":"6","key":"1627_CR51","doi-asserted-by":"publisher","first-page":"953","DOI":"10.1016\/j.jpeds.2009.12.016","volume":"156","author":"C Hampp","year":"2010","unstructured":"Hampp C, Saidi AS, Winterstein AG. Palivizumab utilization and compliance: trends in respiratory syncytial virus prophylaxis in Florida. J Pediatr. 2010;156(6):953\u20139.e1.","journal-title":"J Pediatr"},{"key":"1627_CR52","first-page":"45","volume":"7","author":"M Linder","year":"2015","unstructured":"Linder M, Bystr\u00f6m C, Kieler H, Bergman G, Haerskjold A. Use of palivizumab is underestimated in the Swedish Prescribed Drug Register - implications for register-based drug studies. Clin Epidemiol. 2015;7:45\u201351.","journal-title":"Clin Epidemiol"},{"issue":"10","key":"1627_CR53","doi-asserted-by":"publisher","first-page":"e061746","DOI":"10.1136\/bmjopen-2022-061746","volume":"12","author":"M Damkjaer","year":"2022","unstructured":"Damkjaer M, Loane M, Urh\u00f8j SK, Ballardini E, Cavero-Carbonell C, Coi A, et al. Preterm birth and prescriptions for cardiovascular, antiseizure, antibiotics and antiasthmatic medication in children up to 10 years of age: a population-based data linkage cohort study across six European regions. BMJ Open. 2022;12(10):e061746.","journal-title":"BMJ Open"},{"issue":"1","key":"1627_CR54","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1146\/annurev-virology-012420-022445","volume":"7","author":"M Moriyama","year":"2020","unstructured":"Moriyama M, Hugentobler WJ, Iwasaki A. Seasonality of Respiratory Viral Infections. Annu Rev Virol. 2020;7(1):83\u2013101.","journal-title":"Annu Rev Virol"},{"issue":"1","key":"1627_CR55","doi-asserted-by":"publisher","first-page":"20469","DOI":"10.1038\/s41598-020-76888-4","volume":"10","author":"ST Ali","year":"2020","unstructured":"Ali ST, Tam CC, Cowling BJ, Yeo KT, Yung CF. Meteorological drivers of respiratory syncytial virus infections in Singapore. Sci Rep. 2020;10(1):20469.","journal-title":"Sci Rep"},{"key":"1627_CR56","doi-asserted-by":"publisher","first-page":"1013","DOI":"10.15585\/mmwr.mm7029a1","volume":"70","author":"SJ Olsen","year":"2021","unstructured":"Olsen SJ, Winn AK, Budd AP, Prill MM, Stell J, Midgley CM, et al. Changes in Influenza and Other Respiratory Virus Activity During the COVID-19 Pandemic \u2014 United States, 2020\u20132021. MMWR Morb Mortal Wkly Rep. 2021;70:1013\u20139.","journal-title":"MMWR Morb Mortal Wkly Rep"},{"issue":"3","key":"1627_CR57","doi-asserted-by":"publisher","first-page":"549","DOI":"10.1093\/cid\/ciac120","volume":"75","author":"G Indolfi","year":"2022","unstructured":"Indolfi G, Resti M, Zanobini A. Associazione Ospedali Pediatrici Italiani Research Group on Bronchiolitis. Outbreak of Respiratory Syncytial Virus Bronchiolitis in Italy. Clin Infect Dis. 2022;75(3):549\u201350.","journal-title":"Clin Infect Dis"},{"issue":"1","key":"1627_CR58","doi-asserted-by":"publisher","first-page":"2884","DOI":"10.1038\/s41467-022-30485-3","volume":"13","author":"JS Eden","year":"2022","unstructured":"Eden JS, Sikazwe C, Xie R, Deng YM, Sullivan SG, Michie A, et al. Off-season RSV epidemics in Australia after easing of COVID-19 restrictions. Nat Commun. 2022;13(1):2884.","journal-title":"Nat Commun"},{"key":"1627_CR59","doi-asserted-by":"publisher","first-page":"938372","DOI":"10.3389\/fmicb.2022.938372","volume":"13","author":"R Jia","year":"2022","unstructured":"Jia R, Lu L, Su L, Lin Z, Gao D, Lv H, et al. Resurgence of Respiratory Syncytial Virus Infection During COVID-19 Pandemic Among Children in Shanghai. China Front Microbiol. 2022;13:938372.","journal-title":"China Front Microbiol"},{"key":"1627_CR60","doi-asserted-by":"crossref","unstructured":"Loconsole D, Centrone F, Rizzo C, Caselli D, Orlandi A, Cardinale F, et al. Out-of-Season Epidemic of Respiratory Syncytial Virus during the COVID-19 Pandemic: The High Burden of Child Hospitalization in an Academic Hospital in Southern Italy in 2021. Children (Basel). 2022;9(6)","DOI":"10.3390\/children9060848"},{"issue":"6","key":"1627_CR61","doi-asserted-by":"publisher","first-page":"1587","DOI":"10.1007\/s15010-022-01889-6","volume":"50","author":"T Tenenbaum","year":"2022","unstructured":"Tenenbaum T, Doenhardt M, Diffloth N, Berner R, Armann JP. High burden of RSV hospitalizations in Germany 2021-2022. Infection. 2022;50(6):1587\u201390.","journal-title":"Infection."}],"container-title":["Italian Journal of Pediatrics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13052-024-01627-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13052-024-01627-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13052-024-01627-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,3,25]],"date-time":"2024-03-25T10:17:56Z","timestamp":1711361876000},"score":1,"resource":{"primary":{"URL":"https:\/\/ijponline.biomedcentral.com\/articles\/10.1186\/s13052-024-01627-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,3,25]]},"references-count":61,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2024,12]]}},"alternative-id":["1627"],"URL":"https:\/\/doi.org\/10.1186\/s13052-024-01627-8","relation":{},"ISSN":["1824-7288"],"issn-type":[{"value":"1824-7288","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,3,25]]},"assertion":[{"value":"14 July 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 March 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 March 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The present study, in accordance with national legislation regarding observational study, was notified to the local ethical committee (Comitato Etico Lazio 1, protocol number 1133). Consent to participate is not applicable for this study.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"CV, RC, FH have disclosed that they are employees of IQVIA. GDL and BO are AstraZeneca employees. The remaining authors have no conflict of interest to declare.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"56"}}